Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 23;14(15):1584.
doi: 10.3390/diagnostics14151584.

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas

Affiliations

Assessment of Ki-67 Proliferative Index in Cytological Samples of Nodal B-Cell Lymphomas

Mojca Založnik et al. Diagnostics (Basel). .

Abstract

Background: The Ki-67 proliferative index (PI) is part of the diagnosis of nodal B-cell lymphoma (nBCL), but its determination in cytological samples is not standardized. We aimed to establish an approach for the accurate determination of the Ki-67 PI in cytological slides to differentiate between indolent and aggressive nBCLs.

Methods: Patients diagnosed with nBCL by fine-needle aspiration biopsy and subsequent excision biopsy were included. Cell suspensions were prepared from biopsy samples for CD3/Ki-67 double immunocytochemical staining and flow-cytometric verification of lymphoma B-cell counts. The Ki-67 PI was assessed by manual counting and eyeballing in cytology and eyeballing in histology. The cut-off values for the differentiation between aggressive and indolent lymphomas were determined for each method.

Results: A strong correlation between manual and flow-cytometric counting of lymphoma B cells was confirmed (interclass correlation coefficient (IC coef.) = 0.78). The correlation of the Ki-67 PI determined in cytological and histological slides was also strong (IC coef. > 0.80). Histologically, 55 cases were classified as indolent and 31 as aggressive nBCLs. KI-67 PI cut-off values of 28.5%, 27.5%, and 35.5% were established for manual counting and eyeballing in cytology and eyeballing in histology, respectively, with high sensitivity and specificity.

Conclusions: The Ki-67 PI, assessed by manual counting and eyeballing in cytological samples, accurately differentiates between indolent and aggressive nBCLs.

Keywords: Ki-67 proliferative index; eyeballing; fine-needle aspiration biopsy; flow cytometry; immunocytochemistry; immunohistochemistry; lymph node biopsy; manual counting; non-Hodgkin nodal B-cell lymphomas.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Visual description of the study design. Created with Biorender.com.
Figure 2
Figure 2
Dual Ki-67/CD3 immunocytochemical staining on methanol-fixed cytospins of cytological samples. T cells can be identified by unstained nuclei and red-stained cytoplasm for CD3 (as indicated by the red arrow), or by brown-stained nuclei for Ki-67 and red-stained cytoplasm for CD3 (as indicated by the yellow arrow). Lymphoma B cells can be identified as cells with brown-stained nuclei for Ki-67 and unstained cytoplasm (as indicated by the white arrow) (400× magnification).
Figure 3
Figure 3
ROC curves for the differentiation between indolent and aggressive nodal BCHLs using Ki-67 PI for manual counting and eyeballing in cytological samples.

Similar articles

References

    1. Li L.T., Jiang G., Chen Q., Zheng J.N. Ki67 is a promising molecular target in the diagnosis of cancer (review) Mol. Med. Rep. 2015;11:1566–1572. doi: 10.3892/mmr.2014.2914. - DOI - PubMed
    1. He X., Chen Z., Fu T., Jin X., Yu T., Liang Y., Zhao X., Huang Z. Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: Evidence from a systematic meta-analysis. BMC Cancer. 2014;14:153. doi: 10.1186/1471-2407-14-153. - DOI - PMC - PubMed
    1. Babu G., Lakshmaiah K., Dasappa L., Babu S., Abraham L., Premalatha C., Rao C., Rajeev L., Rudresha A., Lokesh K., et al. Ki-67 and subtype as prognostic and predictive markers of diffuse large B-Cell lymphoma. Clin. Cancer Investig. J. 2017;6:97–102.
    1. Mudassar M., Hameed S., Aslam S., Majeed R., Khan R.U., Majeed M. Ki-67 Proliferative Index in The Non-Hodgkin’s Lymphoma and Its Clinical Significance. Ann. Punjab Med. Coll. 2019;13 doi: 10.29054/apmc/2019.64. - DOI
    1. Vogt N., Klapper W. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: Clinical correlation and insights into disease progression. Histopathology. 2013;62:334–342. doi: 10.1111/his.12009. - DOI - PubMed

LinkOut - more resources